Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Tables)

v3.20.2
Related Party Transactions (Tables)
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Schedule of Incurred Expenses of Minority Shareholders

During the three and six months ended June 30, 2020 and 2019 the Company incurred the following expenses with the minority shareholders of Lucid Diagnostics Inc.:

 

   

For the three months ended

June 30,

   

For the six months ended  

June 30,

 
    2020     2019     2020     2019  
CWRU patent related fees   $ 27     $ 47     $ 59     $ 78  
Clinical supplies – EsoCheck                 15        
EsoGuard Physician Inventors’ consulting agreements     15       36       53       74  
Stock based compensation expense     6       24       12       48  
Total   $ 48     $ 107     $ 139     $ 200